Moffitt Cancer Center and Aptose Biosciences to Present Data on a Novel Class of Dual-Targeting Bromodomain / Kinase Inhibitors at 57th Annual American Society of Hematology (ASH) Meeting Dec 3, 2015 08:00AM
Aptose Biosciences Announces Collaborations for New Multi-Targeting Epigenetic Therapeutic Agents Nov 10, 2015 08:30AM